MedPath

Xylazine hydrochloride

Xylazine Hcl

Approved
Approval ID

acef72e9-0baf-4a93-8c5f-e4f5096e4079

Product Type

BULK INGREDIENT - ANIMAL DRUG

Effective Date

Apr 18, 2022

Manufacturers
FDA

LETCO MEDICAL, LLC

DUNS: 079891426

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

xylazine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62991-1624
Product Classification
G
Generic Name
xylazine hydrochloride
Product Specifications
Route of AdministrationNOT APPLICABLE
Effective DateApril 18, 2022
FDA Product Classification

INGREDIENTS (1)

XYLAZINE HYDROCHLORIDEActive
Quantity: 1 g in 1 g
Code: NGC3S0882S
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Xylazine hydrochloride - FDA Drug Approval Details